Restorative Dentistry Market Growing at a CAGR of 6.4%

According to the new market research report Restorative Dentistry Market is expected to reach USD 21.27 Billion by 2022 from an estimated USD 15.60 Billion in 2017, at a CAGR of 6.4% during the forecast period.
Read More - https://www.marketsandmarkets.com/PressReleases/restorative-dentistry.asp
Increase in the prevalence of dental diseases (dental caries and edentulism), rising demand for advanced cosmetic dental procedures, growing dental tourism, and increasing dental expenditure are the major factors driving the demand for restorative dentistry. Moreover, the gradual shift towards newer technologies & products and growing focus of companies in emerging markets is expected to offer significant growth opportunities for players in this market.
The report analyzes the global restorative dentistry market by product, end user, and region. Based on product, the global restorative dentistry market is segmented into restorative materials, implants, prosthetics, and restorative equipment. In 2016, the restorative materials segment accounted for the largest share of global restorative dentistry market, mainly due to the growing number of tooth repair procedures, high cost of restorative materials, increasing adoption of customized prosthetics, and increasing demand for cosmetic dentistry.
Based on end user, the restorative dentistry market is segmented into hospitals & clinics, dental schools & research institutes, and dental laboratories. The hospitals & clinics segment accounted for the major share of the global restorative dentistry market and is expected to register the highest CAGR during the forecast period. The large share of this end-user segment is attributed to the increasing number of dental clinics and hospitals especially in emerging markets, rapid adoption of advanced technologies in these settings, and growth in the target patient population.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210042423
The global restorative dentistry market is characterized by a large number of players. The prominent players of this market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), Institut Straumann (Switzerland), 3M Company (US), Zimmer Biomet Holdings, Inc. (US), Ultradent Products, Inc. (US), GC Corporation (Japan), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), Ivoclar Vivadent AG (Liechtenstein), COLTENE Holding (Switzerland), and VOCO (Germany).

Clinical Microbiology Market Size, Application and Product – Global Forecast 2023

According to research report the clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period.

Growth in clinical microbiology market can be attributed to factors such as rising incidence of infectious diseases and growing outbreak of epidemics and increased funding and public-private investments.

Read More: https://www.marketsandmarkets.com/PressReleases/microbiology-testing.asp

Market Size Estimation

A detailed market estimation approach was followed to estimate and validate the size of the clinical microbiology market and other dependent submarkets, as mentioned above. The key players in the clinical microbiology market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. Research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the clinical microbiology market. All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources. All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. The research methodology used to estimate the market size includes the following:

·         The key players in the industry and markets have been identified through extensive secondary research.

·         The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.

·         All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367

Global Microbiology Testing Market, by Application

·         Pharmaceutical Applications

·         Clinical Applications

·         Food Testing Applications

·         Energy Applications

·         Chemical and Material Manufacturing Applications

·         Environmental Applications

Global Clinical Microbiology Market, by Products

• Instruments
• Laboratory Instruments
• Incubators
• Gram Stainers
• Bacterial Colony Counters
• Autoclave Sterilizers
• Microbial Air Samplers
• Anaerobic Culture Systems
• Petri Dish Fillers
• Blood Culture Systems
• Microbial Culture Systems
• Other Laboratory Instruments
• Microbiology Analyzers
• Molecular Diagnostic Instruments
• Microscopes
• Mass Spectrometers
• Reagents
• Pathogen-Specific Kits
• General Reagents

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

newsletter@marketsandmarkets.com

dPCR and qPCR Market worth $6.3 billion by 2024

According to the new market research report dPCR and qPCR Market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8%. The rising incidences of target diseases (such as HIV, malaria, tuberculosis, and cancer) and genetic disorders; increasing use of biomarker profiling for disease diagnosis and monitoring; and successful completion of the Human Genome Sequencing Project are a few key factors driving the growth of this market. In addition, ongoing technological advancements in PCR technologies and support for genomic research have contributed to market growth.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=174151204

Reagents and consumables to dominate the qPCR market in 2019

Reagents and consumables are expected to account for the largest share among qPCR product categories in 2019. The large share of this segment is due to the expanding applications of qPCR (owing to its technological benefits over traditional PCR), growing private-public funding for life science research, and the rising number of probe-based multiplex genetic analysis procedures (that require the analysis of low-volume gene samples).

Instruments to be the fastest-growing segment among dPCR products during the forecast period

The dPCR instruments segment is expected to grow at the fastest CAGR among dPCR products during the forecast period. The high growth of this segment will be driven by the procedural benefits offered by dPCR over qPCR (such as reduced throughput time, elimination of reference standards, absolute sample quantification, and high accuracy), growing demand for dPCR (particularly in forensics and drug discovery), and the rising number of dPCR-based genetic research activities across the globe.

Geographically, Asia Pacific is expected to be the fastest-growing market segment

North America accounts for the largest share of the dPCR and qPCR market. However, the Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The high growth of this segment is mainly attributed to the ongoing expansion & modernization of healthcare infrastructure in emerging Asian countries, increasing number of research projects in China, India, and Japan in the fields of genomics and cancer, rising outsourcing of clinical research to Asia-based CROs by leading drug manufacturing companies, and continuous government support for genomics-based research activities in emerging Asia Pacific countries.

Request For Free Sample:
https://www.marketsandmarkets.com/requestsample.asp?id=174151204

The major players operating in the dPCR and qPCR market are Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Promega Corporation (US), Eppendorf AG (Germany), and Analytik Jena AG (Germany).

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com

Genome Engineering Market grow at a CAGR of 14.5% by 2022

According to research report the global Genome Engineering Market is expected to each to USD 6.28 Billion by 2022 from USD 3.19 Billion in 2017, at a CAGR of 14.5%. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. Base year considered for the report is 2016 and the forecast period is 2017–2022.
Read More: https://www.marketsandmarkets.com/PressReleases/genome-editing-engineering.asp
CRISPR to account for the largest technology segment in the genome editing/genome engineering market in 2017
The technology segment of the genome editing market is classified into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is expected to command the largest share of the global genome editing market in 2017. The large share of this segment can be attributed to the potential advantage of CRISPR is its ability to multiplex, that is, to use multiple guide RNAs in parallel to target multiple sites simultaneously in the same cell, making it easier to mutate multiple genes at once or engineer precise deletions in a genomic region.
Biotechnology & pharmaceutical companies to dominate the genome editing/genome engineering market during the forecast period
By end user, the genome editing market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations. The biotechnology & pharmaceutical companies segment is estimated to account for the largest share of the global genome editing market in 2017. The increasing prevalence of infectious diseases and cancer are driving research activities worldwide; this is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000
In 2017, North America is expected to account for the largest share of the genome engineering market, followed by Europe. Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.
Factors such as dearth of skilled professionals and adverse public perception of genetic research are expected to limit the growth of the market to a certain extent. The prominent players include Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Group (UK), GenScript (US), Sangamo BioSciences (US), Integrated DNA Technologies (US), Lonza Group (Switzerland), New England Biolabs (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland).

Changing Trends in Dental Health and Future Growth of Global Oral Care Market

According to research report the global oral care market is projected to reach USD 53.97 billion by 2022 from USD 43.31 billion in 2017, at a CAGR of 4.5%. Factors such as the growing awareness regarding oral hygiene, rising incidence of dental caries and other periodontal diseases, and technological advancements in oral care products are the key drivers of this market.

In this report, the market is segmented on the basis of product, distribution channel, and region. On the basis of product, the global oral care market is segmented into toothpaste, toothbrushes and accessories, mouthwashes/rinses, denture products, dental accessories/ancillaries, and dental prosthesis cleaning solutions. The toothbrushes and accessories segment is expected to register the highest CAGR during the forecast period. Growing innovation in toothbrushes and rising adoption of technologically advanced toothbrushes are fueling the growth of this segment.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246

Based on distribution channel, the market is segmented into consumer stores, retail pharmacies, online distribution, and dental dispensaries. The online distribution segment is expected to grow at the highest rate during the forecast period. The significant growth in e-commerce sectors owing to the expanding number of internet users is a key growth driver for the online distribution segment.

Geographically, the oral care market in the Asia-Pacific (APAC) region is expected to register the highest CAGR during the forecast period. Growth in this regional segment is largely driven by the large population, rising incidence of dental caries, increasing awareness of dental hygiene, and rising disposable incomes in emerging countries in this region.

Emerging markets such as India and China have higher potential for the growth in the oral care market due to the low penetration rates and low per-capita consumption of toothbrushes and toothpaste. Factors such as rising oral health awareness, increasing disposable incomes (which increases the willingness to spend on premium and advanced oral care products), change in consumer habits (brushing twice daily, replacement of toothbrush within 2-3 months), and increasing penetration of toothpastes and toothbrushes in the rural areas are expected to boost the adoption of oral care products in these countries; generating a significant growth opportunity for the players competing in the global oral care/ oral hygiene market in future.

Read More: https://www.marketsandmarkets.com/PressReleases/oral-care.asp

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com

Wearable Medical Devices Market Analysis | Industry Report, 2017-2022

The wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 5.31 Billion in 2016, at a CAGR of 18.3% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.
The key growth strategies adopted by the top companies (profiled in the report) include partnerships, collaborations, and agreements; new product launches and approvals; expansion, and acquisition. 
Read More: https://www.marketsandmarkets.com/PressReleases/wearable-medical-device.asp
Prominent players in the wearable medical device market include Fitbit Inc. (U.S.), Philips Healthcare (Netherlands), Garmin Ltd. (Switzerland), LifeWatch AG. (Switzerland), Omron Corporation (Japan), Drägerwerk AG & Co. KGaA (U.S.), Withings SA.(France), Jawbone Inc. (U.S.) and Polar Electro Oy (Finland).
Activity monitors are expected to dominate the market in 2017.
Based on type, the wearable medical devices market is segmented into activity monitors, smartwatches, smart clothing, and patches. In 2017, the activity monitors segment is expected to account for the largest share of the wearable medical devices market. The high growth in this segment is attributed to factors such as the rising adoption of sedentary and unhealthy lifestyles, rising prevalence of lifestyle diseases, and growing awareness of health and fitness. 
Companies are focused on various organic and inorganic growth strategies such as collaborations, and agreements; new product launches and approvals; expansion, and acquisition. These strategies helped the market players to build a robust position in the market, which helped in increasing demand of customers, and to expand their presence in the global market. 
This research study involves the use of extensive secondary sources; directories; databases such as Hoovers, Bloomberg Business, Factiva, and Avention; white papers; annual reports; company house documents; and SEC filings of companies. 
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973
North America to dominate the wearable medical devices market in 2017
In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to the presence of developed healthcare infrastructure, focus on technological advancements, and the development of interconnected and highly advanced healthcare apps and compatible devices, and the presence of key market players.

Structural Heart Devices Market worth $19.6 billion by 2027

According to research report the global structural heart devices market is expected to reach USD 19.6 billion by 2027 from USD 10.4 billion in 2019, at a CAGR of 8.2%. Growth in the structural heart devices market is mainly driven by factors such as the rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favourable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases. 
Read More: https://www.marketsandmarkets.com/PressReleases/structural-heart-device.asp
The heart valve devices segment is expected to account for the largest share of the market, by product, in 2018
On the basis of products, the structural heart devices market is segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, other devices, and accessories. The heart valve devices segment is further subdivided into transcatheter heart valves and surgical heart valves. The heart valve devices segment is expected to account for the largest market share in 2018. The growing number of transcatheter aortic valve replacement procedures performed across the globe, the efficacy and durability of these products, and the growing number of regulatory approvals for heart valve devices are some of the key factors supporting the growth of this product segment.
By procedure, the replacement procedures segment is expected to command the largest share of the market in 2018
On the basis of procedure, the market has been broadly segmented into replacement procedures and repair procedures. The replacement procedures segment is further segmented into TAVR (transcatheter aortic valve replacement) procedures and SAVR (surgical aortic valve replacement) procedures, while the repair procedures segment is subdivided into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures. The replacement procedures segment is expected to account for the largest share of the structural heart devices market in 2018. This can be attributed to the long-term durability of these procedures and the widespread preference for transcatheter replacement.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=161123753 
North America is expected to dominate the structural heart devices market during the forecast period
Geographically, North America is expected to account for the largest share of the structural heart devices market in 2018, followed by Europe. The large share of North America in the global market is attributed to factors such as the rising prevalence of structural heart diseases, favorable reimbursement scenario for structural heart procedures and devices, technological advancements, and development of innovative devices.
Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK) are the key players in the structural heart devices market. The other players in this market are CryoLife, Inc. (US), Micro Interventional Devices, Inc. (US), Braile Biomédica (Brazil), Lepu Medical Technology (Beijing) Co., Ltd. (China), and TTK Healthcare Limited (India).